Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00548834
Recruitment Status : Completed
First Posted : October 24, 2007
Last Update Posted : September 4, 2013
Information provided by:
UCB Pharma